CYP3A5 and chronic kidney disease: The results showed that elderly patients with CKD who were with wild-type CYP3A5 (n = 5) had increased AUC and Cmax of MDZ (GMR∼2.0–3.0) when compared to healthy young participants with wild-type CYP3A5 (n = 5, Supplementary Table S6).